SCHEMBL9920510

SCHEMBL9920510

c1ccc(-c2cc(-c3ccc(-c4cccc(-c5cc(-c6ccccc6)nc(-c6ccccc6)n5)c4)cc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.66
KMT2A Q03164 10/20 0.66
ALDH1A1 P00352 7/20 0.66
HPGD P15428 7/20 0.66
MAPT P10636 6/20 0.66
KDM4E B2RXH2 4/20 0.66
LMNA P02545 2/20 0.66
GLA P06280 1/20 0.66
NTSR1 P30989 1/20 0.66
ADORA2A P29274 2/20 0.57
ADORA1 P30542 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
NPSR1 Q6W5P4 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
CYP2C19 P33261 1/20 0.51
MAOB P27338 3/20 0.51
MAOA P21397 2/20 0.51
MAPK1 P28482 1/20 0.50
TDP1 Q9NUW8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15458368 1.00 MEN1 (0.66) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL14425575 1.00 MEN1 (0.66) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL27371063 1.00 MEN1 (0.66) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL22352161 1.00 MEN1 (0.66) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL22308601 1.00 MEN1 (0.66) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL14425948 1.00 MEN1 (0.66) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL24270405 0.98 MEN1 (0.69) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL14426019 0.98 MEN1 (0.69) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL22074493 0.98 MEN1 (0.69) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL15458332 0.98 MEN1 (0.68) MEN1KMT2AALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651904-B1 BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2014-11-12 EP disclosed
US-8362246-B2 Bispyrimidines for electronic applications BASF SE (DE) 2013-01-29 US disclosed
US-8362246-B2 Bispyrimidines for electronic applications BASF SE (DE) 2013-01-29 US disclosed
WO-2012080052-A1 BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2012-06-21 WO disclosed
US-20120149904-A1 BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2012-06-14 US disclosed
US-20120149904-A1 BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2012-06-14 US disclosed
US-20070190355-A1 Material for organic electroluminescence device and organic electroluminescence device utilizing the same IDEMITSU KOSAN CO., LTD (JP) 2007-08-16 US disclosed
US-20070190355-A1 Material for organic electroluminescence device and organic electroluminescence device utilizing the same IDEMITSU KOSAN CO., LTD (JP) 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149904-A1 BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS DPYD, TYMP, TYMS MEN1 3376/4885KMT2A 2215/4885ALDH1A1 717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.